Blood test detects pre-Alzheimer’s in Mexican-Americans with 96 percent accuracy
By Jan Jarvis
A blood test developed at UNT Health Science Center detects pre-Alzheimer’s disease in asymptomatic Mexican-Americans with 96 percent accuracy.
The test used blood samples provided by participants in the Health & Aging Brain among Latino Elders (HABLE) study. Hundreds of older Mexican-American residents from the Fort Worth area have participated in this study, which seeks to understand aging in this underserved population.
“These were not people who came into the clinic because they had symptoms of Alzheimer’s,” said Sid O’Bryant, PhD, Director of the Center for Alzheimer’s & Neurodegenerative Disease Research. “These were people in the community whose blood test identified that they had mild memory impairment, which can be pre-Alzheimer’s disease in some people.”
The study further validates UNTHSC research showing a blood test performed as part of a routine physical in a doctor’s office could be used to detect very mild Alzheimer’s – allowing treatment to begin as early as possible. It is especially significant that the blood tests came from participants in the HABLE study, since studies show that Mexican-Americans generally receive their health services in community-based primary care offices, O’Bryant said.
The research, which appears in the Journal of Alzheimer’s Disease, also suggests that blood-based biomarkers for Mexican-Americans may change over time and differ from biomarkers in non-Hispanic whites.
“We think that the biology driving Alzheimer’s may change depending on the stage of the disease,” O’Bryant said.
It is believed that metabolic dysfunction contributes to Alzheimer’s in Mexican-Americans, who are known to have a high incidence of diseases such as diabetes, said Melissa Edwards, M.A., Research Specialist, a University of North Texas graduate student who is the lead author of the study. In non-Hispanic whites, the inflammatory/vascular dysfunction profile is believed to contribute to Alzheimer’s.
But this study showed that inflammation also played a role in pre- Alzheimer’s among Mexican-Americans.
“It could be that inflammation is driving very early memory loss among Mexican Americans,” O’Bryant said. “But once the person has Alzheimer’s, metabolic changes become more important.”
An understanding of the differences in biomarker profiles could make it possible for drugs to be personalized for each patient’s individual needs, O’Bryant said.
“Now we have to figure out who should receive which therapy,” he said. “Anti-inflammatory drugs may be more effective for Mexican-Americans with very early memory loss but diabetes medication may be more appropriate for some patients once they have the disease.”
By Jan Jarvis Forty-six UNT Health Science Center physicians have been recognized as Top Doctors, as selected by their peers for listings in Texas Monthly, Fort Worth Magazine and 360 West. Three UNTHSC physicians from Geriatrics have been recognized as Super Doctors by Texas Monthly...Read more
Jan 18, 2018
By Jan Jarvis As someone who enjoys a good meal, Molly Chang was eager to sample the different dishes that are cooked each week in the Culinary Medicine course. “I love trying out recipes and eating new foods, so cooking with friends and getting a free meal is right up my alley,”...Read more
Jan 17, 2018
By Alex Branch A 2015 School of Health Professions graduate will help put injured Miami Marlins baseball players back on the playing field this summer. Steve Carlin PT, DPT, will treat players throughout the organization as the rehabilitation coordinator at the Marlins spring training faci...Read more
Jan 9, 2018
By Jan Jarvis A traumatic brain injury, or TBI, can happen to anyone at any age, in any place and under all manner of circumstances. An estimated 1.7 million people in the United States experience loss of cognitive and sensorimotor functions following TBI annually. Those who survive ...Read more
Jan 4, 2018